• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

S-苄氧羰基谷胱甘肽:一种哺乳动物乙二醛酶II的竞争性抑制剂。

S-carbobenzoxyglutathione: a competitive inhibitor of mammalian glyoxalase II.

作者信息

Hsu Y R, Norton S J

出版信息

J Med Chem. 1983 Dec;26(12):1784-5. doi: 10.1021/jm00366a027.

DOI:10.1021/jm00366a027
PMID:6644749
Abstract

An effective competitive inhibitor of mammalian glyoxalase II has been synthesized and studied. The compound, S-carbobenzoxyglutathione, is almost totally inactive as an inhibitor of mammalian glyoxalase I. This is in marked contrast to other glyoxalase II competitive inhibitors, which in general are even more effective against glyoxalase I. S-Carbobenzoxyglutathione has found utility as an affinity ligand for the purification of rat liver glyoxalase II, and it may well have use in the study of the glyoxalase enzymes in vivo.

摘要

一种有效的哺乳动物乙二醛酶II竞争性抑制剂已被合成并进行了研究。该化合物,S-苄氧羰基谷胱甘肽,作为哺乳动物乙二醛酶I的抑制剂几乎完全没有活性。这与其他乙二醛酶II竞争性抑制剂形成了显著对比,其他抑制剂通常对乙二醛酶I更有效。S-苄氧羰基谷胱甘肽已被用作纯化大鼠肝脏乙二醛酶II的亲和配体,并且很可能在体内乙二醛酶的研究中有用途。

相似文献

1
S-carbobenzoxyglutathione: a competitive inhibitor of mammalian glyoxalase II.S-苄氧羰基谷胱甘肽:一种哺乳动物乙二醛酶II的竞争性抑制剂。
J Med Chem. 1983 Dec;26(12):1784-5. doi: 10.1021/jm00366a027.
2
S-(nitrocarbobenzoxy)glutathiones: potent competitive inhibitors of mammalian glyoxalase II.
J Med Chem. 1985 Jun;28(6):828-30. doi: 10.1021/jm00383a025.
3
S-fluorenylmethoxycarbonyl glutathione and diesters: inhibition of mammalian glyoxalase II.S-芴甲氧羰基谷胱甘肽和二酯:对哺乳动物乙二醛酶II的抑制作用
Enzyme Protein. 1994;48(3):164-73. doi: 10.1159/000474983.
4
N,S-bis-fluorenylmethoxycarbonylglutathione: a new, very potent inhibitor of mammalian glyoxalase II.N,S-双芴甲氧羰基谷胱甘肽:一种新型、强效的哺乳动物乙二醛酶II抑制剂。
Biochem Mol Biol Int. 1995 Apr;35(4):763-71.
5
Effects of some S-blocked glutathione derivatives on the prevalent glyoxalase II (a form) of rat liver.
Enzyme. 1989;41(3):175-80. doi: 10.1159/000469073.
6
Inhibition by glutathione derivatives of bovine liver glyoxalase II (hydroxyacylglutathione hydrolase) as a probe of the N- and S-sites for substrate binding.
Biochim Biophys Acta. 1986 Mar 28;870(2):219-25. doi: 10.1016/0167-4838(86)90225-6.
7
Glyoxalase II from Zea mays: properties and inhibition study of the enzyme purified by use of a new affinity ligand.
Enzyme. 1989;42(4):189-96. doi: 10.1159/000469032.
8
Presence of a plant-like glyoxalase II in Candida albicans.
Biochem Int. 1990;21(3):397-403.
9
Inhibition of glyoxalase I by the enediol mimic S-(N-hydroxy-N-methylcarbamoyl)glutathione. The possible basis of a tumor-selective anticancer strategy.烯二醇类似物S-(N-羟基-N-甲基氨基甲酰)谷胱甘肽对乙二醛酶I的抑制作用。肿瘤选择性抗癌策略的可能基础。
J Biol Chem. 1992 Dec 15;267(35):24933-6.
10
Small molecule probes of glyoxalase I and glyoxalase II.乙二醛酶I和乙二醛酶II的小分子探针。
Biochim Biophys Acta. 1994 Sep 21;1208(1):127-35. doi: 10.1016/0167-4838(94)90169-4.

引用本文的文献

1
Probing the substrate binding modes and catalytic mechanisms of BLEG-1, a promiscuous B3 metallo-β-lactamase with glyoxalase II properties.探究 BLEG-1 的底物结合模式和催化机制,BLEG-1 是一种具有甘油醛-3-磷酸脱氢酶性质的混杂 B3 金属-β-内酰胺酶。
PLoS One. 2023 Sep 6;18(9):e0291012. doi: 10.1371/journal.pone.0291012. eCollection 2023.
2
Glyoxalase 2: Towards a Broader View of the Second Player of the Glyoxalase System.乙二醛酶2:对乙二醛酶系统第二个参与者的更全面认识
Antioxidants (Basel). 2022 Oct 28;11(11):2131. doi: 10.3390/antiox11112131.
3
The possible role of methylglyoxal metabolism in cancer.
甲基乙二醛代谢在癌症中的可能作用。
J Enzyme Inhib Med Chem. 2021 Dec;36(1):2010-2015. doi: 10.1080/14756366.2021.1972994.
4
A simplified method for the purification of human red blood cell glyoxalase. I. Characteristics, immunoblotting, and inhibitor studies.一种纯化人红细胞乙二醛酶I的简化方法。I. 特性、免疫印迹及抑制剂研究。
J Protein Chem. 1993 Apr;12(2):111-9. doi: 10.1007/BF01026032.